Manhattan Pharmaceuticals, Inc. (MHAN1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
2 GANSEVOORT STREET, 9TH FLOOR NEW YORK, NY 10014

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Manhattan Pharmaceuticals, Inc. develops and commercializes biomedical and pharmaceutical technologies. The company aims to acquire proprietary rights to these technologies, by license or acquiring an ownership interest, fund their research and development and eventually bring the technologies to market.

View SEC Filings from MHAN1 instead.

View recent insider trading info

Funds Holding MHAN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MHAN1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2020-09-09 0

POWER SEAN A CFO, SECRETARY AND TREASURER

  • Officer
633,338 2020-07-16 0

WEISS MICHAEL S CEO AND PRESIDENT

  • Officer
  • Director
14,434,214 2020-06-22 0

CHARNEY LAURENCE N

  • Director
160,997 2020-06-22 0

ECHELARD YANN

  • Director
159,116 2020-06-22 0

HOBERMAN KENNETH

  • Director
158,953 2020-06-22 0

HUME DANIEL

  • Director
134,507 2020-06-22 0

LONIAL SAGAR

  • Director
65,000 2020-06-22 0

KENNEDY WILLIAM JAMES

  • Director
109,633 2020-06-17 0

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
12,788,457 2020-05-05 0

SCHOENEBAUM MARK

125,949 2018-06-26 0

LFB BIOTECHNOLOGIES S.A.S.U.

  • 10% Owner
7,614,855 2015-02-17 0

HERSKOWITZ NEIL

  • Director
80,088 2014-06-06 0

OPUS POINT PARTNERS, LLC

  • 10% Owner
248,013 2011-12-29 0

MORVILLE MALCOLM

  • Director
211,568 2010-03-18 0

SHIMKO DAVID

  • Director
42,313 2010-03-18 0

WEISER MICHAEL

  • FORMER DIRECTOR
No longer subject to file 2010-03-03 0

MCINERNEY TIMOTHY

  • Director
674,007 2010-03-03 0

STEINHART RICHARD I

  • Director
5,633 2010-03-03 0

HOENLEIN MALCOLM

  • FORMER DIRECTOR
No longer subject to file 2010-03-03 0

MCGUINNESS MICHAEL COO & CFO

  • Officer
10,000 2010-03-03 0

ABEL DOUGLAS

  • Director
55,000 2010-03-03 0

NORDIC BIOTECH VENTURE FUND II K/S

  • 10% Owner
0 2008-02-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments